Simultaneous surgery for primary colorectal cancer and metastatic lesions?

References

• Jemal A, Siegel R, Ward E, Cancer Statistics, 2007, CA. Cancer J Clin 2007;57:43–6.
   PubMed Web of Science ®Google Scholar
• Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009;27:3677–83.
   PubMed Web of Science ®Google Scholar
• Köhne CH, Bruce C, Folprecht G, Audision R. Role of new agents in the treatment of colorectal cancer. Surg Oncol 2004;13:75–81.
   PubMed Web of Science ®Google Scholar
• Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005;12:637–45.
   PubMed Web of Science ®Google Scholar
• Mise Y, Imamura H, Hashimoto T, Seyama Y, Aoki T, Hasdegawa K, Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg 2010;251:902–9.
   PubMed Web of Science ®Google Scholar
• Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006;93:465–74.
   PubMed Web of Science ®Google Scholar
• Figueras J, Ramos E, López-Ben S, Torras J, Albiol M, Llado L, Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile? Clin Transl Oncol 2007;9:392–400.
   PubMed Web of Science ®Google Scholar
• Nathan H, de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg 2010;210:755–64; 764–6.
   PubMed Web of Science ®Google Scholar
• House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010;210:744–52, 752–5.
   PubMed Web of Science ®Google Scholar
• Feroci F, Fong Y. Use of clinical score to stage and predict outcome of hepatic resection of metastatic colorectal cancer. J Surg Oncol 2010;102:914–21.
   PubMed Web of Science ®Google Scholar
• Merkel S, Bialecki D, Meyer T, Müller V, Papadopoulus T, Hohenberger W. Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol 2009;100:349–57.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996;77:1254–62.
   PubMed Web of Science ®Google Scholar
• Fong Y, Fortner J, Sun RL, Brennan ME, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–18; discussion 318–21.
   PubMed Web of Science ®Google Scholar
• Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.
   PubMed Web of Science ®Google Scholar
• Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol 2010;22:364–73.
   PubMed Web of Science ®Google Scholar
• Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, Guidelines for resection of colorectal cancer liver metastases. Gut 2006;55(Suppl 3):iii1–8.
   PubMed Web of Science ®Google Scholar
• Primrose JN. Surgery for colorectal liver metastases. Br J Cancer 2010;102:1313–18.
   PubMed Web of Science ®Google Scholar
• John SK, George S, Primrose JN, Fozard JB. Symptoms and signs in patients with colorectal cancer. Colorectal Dis 2011;13:17–25.
   PubMed Web of Science ®Google Scholar
• Isoniemi H, Osterlund P. Surgery combined with oncological treatments in liver metastases from colorectal cancer. Scand J Surg 2011;100:35–41.
   PubMed Web of Science ®Google Scholar
• Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving respectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271–80.
   PubMed Web of Science ®Google Scholar
• Reddy SK, Barbas AS, Clary BM. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 2009;16:2395–410.
   PubMed Web of Science ®Google Scholar
• Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92:1155–60.
   PubMed Web of Science ®Google Scholar
• Petrelli NJ. Perioperative or adjuvant therapy for resectable colorectal hepatic metastases. J Clin Oncol 2008;26:4862–3.
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, Orditura M, Castellano P, Imperatore V, Pinto M, First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008;143:352–8; discussion 358.
   PubMedGoogle Scholar
• Tan EK, Ooi LL. Colorectal cancer liver metastases – understanding the differences in the management of synchronous and metachronous disease. Ann Acad Med Singapore 2010;39:715–19.
   Web of Science ®Google Scholar
• Alwan M, Stubbs R. Local recurrence in patients with synchronous or metachronous colorectal liver metastases – is there a difference? N Z Med J 2005;118:U1631.
   Google Scholar
• Bockhorn M, Frilling A, Frühauf NR, Neuhaus J, Molmenti E, Trarbacht T, Survival of patients with synchronous and metachronous colorectal liver metastases – is there a difference? J Gastrointest Surg 2008;12:1399–405.
   PubMed Web of Science ®Google Scholar
• Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 2002;94:647–57.
   PubMed Web of Science ®Google Scholar
• Pantaleo MA, Astolfi A, Nannini M, Paterini P, Piazzi G, Ercolani G, Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer 2008;99:1729–34.
   PubMed Web of Science ®Google Scholar
• Bedeir A, Krasinskas AM. Molecular diagnostics of colorectal cancer. Arch Pathol Lab Med 2011;135:578–87.
   PubMed Web of Science ®Google Scholar
• Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, DeLong L, Colorectal cancer: mutations in a signaling pathway. Nature 2005;436:792.
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789–99.
   PubMed Web of Science ®Google Scholar
• Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 2011;29:1083–90.
   PubMed Web of Science ®Google Scholar
• Yang AD, Brouquet A, Vauthey JN. Extending limits of resection for metastatic colorectal cancer: risk benefit ratio. J Surg Oncol 2010;102:996–1001.
   PubMed Web of Science ®Google Scholar
• Blyth S, Blakeborough A, Peterson M, Cameron IC, Majeed AW. Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases. Ann R Coll Surg Engl 2008;90:25–8.
   PubMed Web of Science ®Google Scholar
• Larsen LP. Role of contrast enhanced ultrasonography in the assessment of hepatic metastases: A review. World J Hepatol 2010;2:8–15.
   PubMedGoogle Scholar
• Abdalla EK. Portal vein embolization (prior to major hepatectomy) effects on regeneration, respectability, and outcome. J Surg Oncol 2010;102:960–7.
   PubMed Web of Science ®Google Scholar
• Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis 2011;13:252–65.
   PubMed Web of Science ®Google Scholar
• Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011;11:23–30.
   PubMed Web of Science ®Google Scholar
• Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T, Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol 2007;14:1161–9.
   PubMed Web of Science ®Google Scholar
• Hemming AW, Reed AL, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237:686–91.
   PubMed Web of Science ®Google Scholar
• Fong Y, Bentrem DJ. CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg 2006;243:8–9.
   PubMed Web of Science ®Google Scholar
• Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 2009;16:137–44.
   PubMedGoogle Scholar
• Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu Ax. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010;56:430–9.
   PubMed Web of Science ®Google Scholar
• Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005;200:845–53.
   PubMed Web of Science ®Google Scholar
• Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065–72.
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008;371:1007–16.
   PubMed Web of Science ®Google Scholar
• Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 2008;26:5254–60.
   PubMed Web of Science ®Google Scholar
• Hillingsø JG, Wille-Jørgensen P. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer –a systematic review. Colorectal Dis 2009;11:3–10.
   PubMed Web of Science ®Google Scholar
• Dimitroulis D, Nikiteas N, Troupis T, Patsouras D, Skandalakis P, Kouraklis G. Role of surgery in colorectal liver metastases: too early or too late? World J Gastroenterol 2010;16:3484–90.
   PubMed Web of Science ®Google Scholar
• Rupp KD, Dohmoto M, Meffert R, Holzgreve A, Hohlbach G. Cancer of the rectum – palliative endoscopic treatment. Eur J Surg Oncol 1995;21:644–7.
   PubMedGoogle Scholar
• Feo L, Schaffzin DM. Colonic stents: the modern treatment of colonic obstruction. Adv Ther 2011;28:73–86.
   PubMed Web of Science ®Google Scholar
• Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008;25:430–5.
   PubMed Web of Science ®Google Scholar
• Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–61.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Rivera F, Berry S, Kretzschmar A, Michael M, DiBartolomeo M, Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 2009;20:1842–7.
   PubMed Web of Science ®Google Scholar
• Masi G, Vasile E, Loupakis F, Cupini S, Fornaro L, Baldi G, Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst 2011;103:21–30.
   PubMed Web of Science ®Google Scholar
• Kemeny NE, Jarnagin WR, Capanu M, Fong Y, Gewirtz AN, Dematteo RP, Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol 2011;29:884–9.
   PubMed Web of Science ®Google Scholar
• Broquet A, Nordlinger B. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials. J Surg Oncol 2010;102:932–6.
   PubMed Web of Science ®Google Scholar
• Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006;24:3939–45.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Köhne CH, Láng I, Folprecht G, Nowacki MP, Cascinu S, Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol 2011;29:2011–19.
   PubMed Web of Science ®Google Scholar
• Jain VK, Hawkes EA, Cunningham D. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer. Clinical Colorectal Cancer 2011; In press.
   PubMedGoogle Scholar
• Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J, Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003;52:568–73.
   PubMed Web of Science ®Google Scholar
• Rogue MP, Di Fiore F, Langlois S, Scotte M, Tenière P, Paillot B. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol 2004;28:434–7.
   PubMedGoogle Scholar
• Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347–53.
   PubMed Web of Science ®Google Scholar
• Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Interval debulking surgery for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 2009;21:CD006014.
   Google Scholar
• Capussotti L, Ferrero A, Viganò L, Ribero D, Lo Tesoriere R, Polastri R. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 2007;14:195–201.
   PubMed Web of Science ®Google Scholar
• Slupski M, Wlodarczyk Z, Jasinski M, Masztalerz M, Tujakowski J. Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg 2009;52:E241–4.
   Web of Science ®Google Scholar
• Chen J, Li Q, Wang C, Zhu H, Shi Y, Zhao G. Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis. Int J Colorectal dis 2011;26:191–9.
   PubMed Web of Science ®Google Scholar
• Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 2010;210:934–41.
   PubMed Web of Science ®Google Scholar